Skip to main content
Clinical Trials/IRCT20220516054874N10
IRCT20220516054874N10
Not yet recruiting
Phase 2

Evaluation of the effectiveness of vitamin E on the levels of liver enzymes (ALT and AST) in patients with high-dose statins-induced hepatic failure

Mashhad University of Medical Sciences0 sites56 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Mashhad University of Medical Sciences
Enrollment
56
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients receiving high doses of statins (Atorvastatin with a dose of more than 40 mg or Rosuvastatin with a dose of more than 20 mg)
  • Abnormalities in liver function tests (increased aminotransferase level equal to or more than 1\.5 and less than 3 times the upper limit of the normal range)
  • Consent to admission to the study
  • No previous medical history of liver disease or elevated aminotransferase before statin initiation

Exclusion Criteria

  • Receiving other drugs that may affect the increase of liver enzymes
  • Elevation of LFT equal to or greater than 3 times

Outcomes

Primary Outcomes

Not specified

Similar Trials